Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232012067
Abstract: Ovarian cancer is considered one of the most aggressive and deadliest gynecological malignancies worldwide. Unfortunately, the therapeutic methods that are considered the gold standard at this moment are associated with frequent recurrences. Survival in ovarian… read more here.
Keywords: focus therapeutic; therapeutic target; immune checkpoint; ovarian cancer ... See more keywords